Molly Bowen

CRS:

BJMC

Role:

Communications

Position:

Communications Associate

Email:

molly.bowen@jhmi.edu

Phone:

410-955-9948

Molly Bowen is Communications Associate at the Johns Hopkins Center for Clinical Global Health Education (CCGHE). She establishes and maintains systems for information management, and devises strategies, develops content, and manages production and workflow for organizational reporting, donor relations, media outreach, marketing and promotional materials, and the CCGHE website. She also is charged with communications for the Baltimore-Washington-India Clinical Trials Unit.

Prior to joining CCGHE in March 2015, Molly worked for more than 15 years with Dr. D.A. Henderson, first joining the Johns Hopkins Center for Civilian Biodefense Studies in 1999, and moving with the group in 2003 to found the UPMC Center for Health Security. As the first non-faculty member hired, Molly established administrative, finance, and communications functions for the organization, and served for 10 years as Senior Communications Specialist. Prior to that position, she worked for 9 years with ORBIS Associates, non-profit American Indian owned and managed educational consulting firm in Washington, DC.

She has a BA in American Studies from Keene State College, Keene, New Hampshire.

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5302:  BioBank for Surrogate Marker Research for TB...

Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...

Read More

A5345, Identification of Biomarkers to Predict Time to...

Brief Summary: The purpose of this study is to collect information about what happens when people pause, or temporarily stop...

Read More

P2001 (DAIDS ID 12026): Evaluating the Pharmacokinetics,...

TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...

Read More

A5128: Consent for Use of Stored Patient Specimens for...

The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...

Read More

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More